Clinical Trials Directory

Trials / Unknown

UnknownNCT01175928

Pneumatic Medicine: A Transformative Treatment for Diabetic Peripheral Neuropathy

Phase 2 Study of the NormaTec PCD in the Treatment of Diabetic Peripheral Neuropathy

Status
Unknown
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
NormaTec Industries LP · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the efficacy of the NormaTec PCD, a non-invasive pneumatic compression device with the patented peristaltic pulse pneumatic waveform, in the treatment of Diabetic Peripheral Neuropathy (DPN). The study will compare treatment with a NormaTec PCD and a sham device to assess whether the NormaTec PCD improves the signs and symptoms of DPN.

Detailed description

Diabetes frequently leads to decreased sensation in the legs caused by diabetic peripheral neuropathy (DPN). DPN is an important risk factor for the development of foot ulceration, one of the most common causes for hospital admissions and lower-limb amputations among diabetic patients. However, to date there are no medications currently approved by the Food and Drug Administration to treat DPN. The goal of this research project is to assess the effectiveness of a non-invasive, patented peristaltic pulse pneumatic compression device (the NormaTec PCD) in a home treatment program to improve the symptoms of DPN (e.g. numbness, pain, and tingling in the legs) and the underlying functioning of the nerves in the legs (as determined by sensory perception assessments and Nerve Conduction Studies testing). In this prospective, randomized, double-blind study, subjects will be randomly placed in one of two groups: a control group using a sham NormaTec PCD ("placebo"); and an experimental group using a NormaTec PCD.

Conditions

Interventions

TypeNameDescription
DEVICESham deviceHome treatment with PCD to both legs: 2 sessions of 1 hour duration every day
DEVICENormaTec PCD (Peristaltic Pulse PCD)Home treatment with PCD to both legs: 2 sessions of 1 hour duration every day

Timeline

Start date
2010-10-01
Primary completion
2012-09-01
Completion
2012-09-01
First posted
2010-08-05
Last updated
2012-04-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01175928. Inclusion in this directory is not an endorsement.